Teva Pharmaceutical Industries (TEVA) Return on Capital Employed Growth (3y) (2012 - 2026)
Teva Pharmaceutical Industries (TEVA) Return on Capital Employed Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,902.00 |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | -96.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,301.00 |
| Dec 31, 2025 | 1,475.00 |
| Sep 30, 2025 | 992.00 |
| Jun 30, 2025 | 602.00 |
| Mar 31, 2025 | -3.00 |
| Dec 31, 2024 | -577.00 |
| Sep 30, 2024 | -384.00 |
| Jun 30, 2024 | 1,104.00 |
| Mar 31, 2024 | 960.00 |
| Dec 31, 2023 | 1,107.00 |
| Sep 30, 2023 | 547.00 |
| Jun 30, 2023 | -476.00 |
| Mar 31, 2023 | -361.00 |
| Dec 31, 2022 | -571.00 |
| Sep 30, 2022 | 498.00 |
| Jun 30, 2022 | 534.00 |
| Mar 31, 2022 | 814.00 |
| Dec 31, 2021 | 805.00 |
| Sep 30, 2021 | 2,801.00 |
| Jun 30, 2021 | 1,263.00 |